glp 1 drugs definition Comparing Ozempic, Wegovy and Other GLP-1 GLP-1 agonists are often called

Pediatric and Adolescent Obesity Treatment: Since FDA approval in 2022, GLP-1 receptor agonists have been prescribed for individuals aged 12 years and older with obesity (BMI 95th percentile)

That's the clinical rationale for prescribing them, not just weight optics

Adequate amino acid availability is required to sustain protein synthesis, antioxidant synthesis, and metabolic homeostasis, and reductions in amino acid supply may therefore influence the capacity of redox-buffering systems that maintain oxidative stability because glutathione synthesis depends on cysteine and related amino acid precursors [78, 79]

The health effects of long-term use of these medications for weight loss are unknown and still in clinical trials

10.1056/NEJMoa1911303 [DOI] [PubMed] [Google Scholar] 78

In a randomised controlled trial with overweight/obese people, once-weekly survodutide induced dose-dependent mean body-weight changes up to 14.9% for those assigned to the maximum dose of 4.8 mg, compared to 2.8% with placebo